Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
28.58
+1.29 (4.73%)
At close: Apr 24, 2026, 4:00 PM EDT
28.63
+0.05 (0.17%)
After-hours: Apr 24, 2026, 5:31 PM EDT
Pharvaris Stock Forecast
Stock Price Forecast
The 11 analysts that cover Pharvaris stock have a consensus rating of "Buy" and an average price target of $41.82, which forecasts a 46.33% increase in the stock price over the next year. The lowest target is $25 and the highest is $60.
Price Target: $41.82 (+46.33%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pharvaris stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 6 | 6 | 6 | 7 | 8 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 9 | 9 | 9 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy Initiates $42 | Buy | Initiates | $42 | +46.96% | Apr 9, 2026 |
| Wedbush | Wedbush | Buy Maintains $41 → $42 | Buy | Maintains | $41 → $42 | +46.96% | Apr 7, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $52 → $51 | Buy | Maintains | $52 → $51 | +78.45% | Apr 6, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $52 | Buy | Initiates | $52 | +81.95% | Mar 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +109.94% | Mar 3, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
41.97M
EPS This Year
-3.01
from -2.97
EPS Next Year
-2.59
from -3.01
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 106.6M | ||||||
| Avg | n/a | 42.0M | ||||||
| Low | n/a | 2.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.67 | -1.68 | ||||||
| Avg | -3.01 | -2.59 | ||||||
| Low | -3.17 | -3.92 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.